Metropolitan Life Insurance CO Angion Biomedica Corp. Transaction History

Metropolitan Life Insurance CO

  • $2.27 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$2.35 - $9.95 $17,439 - $73,838
-7,421 Closed
0 $0
Q3 2021

Jun 21, 2023
BUY
$9.31 - $13.25 $69,089 - $98,328
7,421 New
7,421 $72,000
Q3 2021

Mar 30, 2023
BUY
$9.31 - $13.25 $69,089 - $98,328
7,421 New
7,421 $72,000
Q3 2021

Nov 15, 2021
BUY
$9.31 - $13.25 $69,089 - $98,328
7,421 New
7,421 $73,000

About Angion Biomedica Corp.

ANGN Quotes by TradingView
  • Ticker ANGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,113,300
  • Description
  • Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...
More about ANGN
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email